化痰通络汤加减联合常规疗法治疗痰瘀阻络型脑梗死临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R743.33

基金项目:


Clinical Study on Treatment of Modified Huatan Tongluo Decoction Combined with Conventional Therapy for Cerebral Infarction of Phlegm and Blood Stasis Obstruct⁃ ing the Collaterals Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察化痰通络汤加减联合常规疗法治疗痰瘀阻络型脑梗死的临床效果。方法:选取2019年 1月—2023年12月在广州市海珠区中医医院康复医学科治疗的80例痰瘀阻络型脑梗死住院患者为研究对象, 通过随机数字表法分为对照组和治疗组各40例。2组均予常规内科基础治疗与康复训练,治疗组加用化痰通络 汤加减治疗,2 组疗程均为2 周。治疗前后评估2 组患者的中医证候评分、美国国立卫生研究院卒中量表 (NHISS) 评分、Barthel指数(BI) 评分,检测血红细胞比容(HCT)、纤维蛋白原(FIB) 水平,比较2组的临 床疗效与不良反应发生率。结果:治疗后,治疗组总有效率高于对照组(P<0.05)。2 组中医证候积分、 NIHSS评分均较治疗前减少,BI评分均较治疗前增加,差异均有统计学意义(P<0.05)。治疗组中医证候积 分、NIHSS评分均低于对照组,BI评分高于对照组,差异均有统计学意义(P<0.05)。2组HCT、FIB水平均较 治疗前降低(P<0.05)。治疗组HCT、FIB水平均低于对照组(P<0.05)。2组不良反应发生率比较,差异无统 计学意义(P>0.05)。结论:应用化痰通络汤加减联合常规疗法治疗痰瘀阻络型脑梗死患者,相较于单纯应用 常规疗法治疗,可提高临床疗效,提升患者的日常生活自理能力,改善生活质量,且安全性良好。

    Abstract:

    Abstract: Objective: To observe the clinical effect of modified Huatan Tongluo Decoction combined with conventional therapy in the treatment of cerebral infarction of phlegm and blood stasis obstructing the collaterals type. Methods:A total of 80 inpatients with cerebral infarction of phlegm and blood stasis obstructing the collaterals type, who were treated in the Department of Rehabilitation Medicine of Guangzhou Haizhu Hospital of Traditional Chinese Medicine from January 2019 to December 2023,were selected as the research subjects and divided into a control group and a treatment group,with 40 cases in each group,using the random number table method. Both groups were given conventional internal medicine basic treatment and rehabilitation training, while the treatment group was additionally treated with modified Huatan Tongluo Decoction. The treatment course for both groups was two weeks. Before and after treatment, the traditional Chinese medicine syndrome scores, National Institutes of Health Stroke Scale(NIHSS) scores,and Barthel Index(BI)scores of the patients in both groups were assessed,and the levels of hematocrit(HCT) and fibrinogen(FIB)were detected. The clinical efficacy and incidence of adverse reactions were compared between the two groups. Results:After treatment,the total effective rate in the treatment group was higher than that in the control group (P<0.05). The traditional Chinese medicine syndrome scores and NIHSS scores in both groups reduced compared with those before treatment, and the BI scores increased compared with those before treatment, with statistically significant differences(P<0.05). The traditional Chinese medicine syndrome scores and NIHSS scores in the treatment group were lower than those in the control group, and the BI score was higher than that in the control group,with statistically significant differences(P<0.05). The levels of HCT and FIB in both groups reduced compared with those before treatment(P<0.05). The levels of HCT and FIB in the treatment group were lower than those in the control group(P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion: The application of the modified Huatan Tongluo Decoction combined with conventional therapy in the treatment of patients with cerebral infarction of phlegm and blood stasis obstructing the collaterals type, compared with the sole use of conventional therapy, can improve clinical efficacy, enhance the patients' ability to take care of themselves in daily life,improve the quality of life,and ensure good safety.

    参考文献
    相似文献
    引证文献
引用本文

刘均仪,方亮,林敏霞,徐珊,王袖平.化痰通络汤加减联合常规疗法治疗痰瘀阻络型脑梗死临床研究[J].新中医,2025,57(22):54-58

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-11-26
  • 出版日期:
文章二维码